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Summary 
Immunity against viruses and plasmids provided by CRISPR-Cas systems relies on a ribonucleoprotein 
effector complex that triggers the degradation of invasive nucleic acids (NA). Effector complexes of 
Type I (Cascade) and II (Cas9-dual RNA) target foreign DNA. Intriguingly, the genetic evidence 
suggests that Type III-A Csm complex targets DNA whereas biochemical data show that III-B Cmr 
complex cleaves RNA. Here we aimed to investigate NA specificity and mechanism of CRISPR-
interference for the Streptococcus thermophilus Csm (III-A) complex (StCsm). When expressed in 
Escherichia coli, two complexes of different stoichiometry co-purified with 40- and 72-nt crRNA 
species, respectively. Both complexes targeted RNA and generated multiple cuts at 6-nt-intervals. The 
Csm3 protein, present in multiple copies in both Csm complexes, acts as endoribonuclease. In the 
heterologous E.coli host StCsm restricted MS2 RNA phage dependently on Csm3 nuclease. Thus, our 
results demonstrate that the Type III-A StCsm complex targets RNA and not DNA.  
 
Highlights 
 
9 Streptococcus thermophilus Type III-A Csm (StCsm) complex targets RNA 
9 Multiple cuts are introduced in the target RNA at 6-nt-intervals 
9 Csm3 protein subunits are responsible for an endoribonuclease activity of the complex 
9 StCsm complex offers a novel programmable tool for RNA-degradation or modification 
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Introduction 
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) together with Cas (CRISPR-
associated) proteins provide RNA-mediated adaptive immunity against viruses and plasmids in bacteria 
and archaea (Terns and Terns, 2014). Immunity is acquired through the integration of invader-derived 
nucleic acid (NA) VHTXHQFHVDVµVSDFHUV¶LQWRWKH&5,635ORFXVRIWKHKRVW&5,635DUUD\VDUHIXUWKHU
transcribed and processed into small interfering CRISPR RNAs (crRNAs) that together with Cas 
proteins assemble into a ribonucleoprotein (RNP) complex which, using crRNA as a guide, locates and 
degrades the target NA. CRISPR-Cas systems have been categorized into three major Types (I-III) that 
differ by the structural organization of RNPs and NA specificity (Makarova et al., 2011b). 
Type I and II systems provide immunity against invading DNA. In Type I systems crRNAs are 
incorporated into a multisubunit RNP complex called Cascade (CRISPR-associated complex for 
antiviral defense) that binds to the matching invasive DNA and triggers degradation by the Cas3 
nuclease (Brouns et al., 2008; Sinkunas et al., 2013; Westra et al., 2012). In Type II systems, CRISPR-
mediated immunity solely relies on the Cas9 protein. It binds a dual RNA into the RNP effector 
complex, which then VSHFL¿FDOO\ FXWV the matching target DNA, introducing a double strand break 
(Gasiunas et al., 2012; Jinek et al., 2012). In Type I and II CRISPR-Cas systems, the target site binding 
and cleavage requires a short nucleotide sequence (protospacer-adjacent motif, or PAM) in the vicinity 
of the target (Mojica et al., 2009). Target DNA strand separation, necessary for the crRNA binding, is 
initiated at PAM and propagates in a directional manner through the protospacer sequence to yield the 
R-loop intermediate, one strand of which is engaged into the heteroduplex with crRNA, while the other 
strand is displaced into solution (Sternberg et al., 2014; Szczelkun et al., 2014). Thus, despite 
differences in their architecture, Type I and II RNP complexes share three major features: i) they act on 
the invasive double-stranded DNA (dsDNA), e.g., viral DNA or plasmids, ii) they require the presence 
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of a PAM sequence in the vicinity of the target site, and iii) they generate an R-loop as a reaction 
intermediate. 
Intriguingly, Type III CRISPR-Cas systems are believed to target either DNA (Type III-A) or RNA 
(Type III-B) (Makarova et al., 2011b). In the III-B systems Cas RAMP proteins (Cmr) and crRNA 
assemble into a multisubunit RNP complex. Using crRNA as a guide, this complex in vitro binds 
single-stranded RNA (ssRNA) in a PAM-independent manner and triggers the degradation of target 
RNA (Hale et al., 2009; Staals et al., 2013; Zhang et al., 2012). The Cmr-effector complex is comprised 
of six Cmr proteins (Cmr1, Cas10, Cmr3-6) that are important for efficient target RNA cleavage, 
however roles of the individual Cmr proteins and the ribonuclease (RNase) component have yet to be 
identified. Cmr1, Cmr3, Cmr4 and Cmr6 are predicted RNA-binding proteins that share a ferredoxin-
like fold and resemble RNA-recognition motifs (RRMs) identified in RNA-binding proteins (Terns and 
Terns, 2014). 
The Cas genes encoding the RNA-targeting III-B (Cmr) and DNA-targeting Type III-A (Csm) effector 
complexes share a partial synteny (Makarova et al., 2011a). In Staphylococcus epidermidis the DNA-
targeting Csm complex (SeCsm) is comprised of Cas10, Csm2, Csm3, Csm4, and Csm5 proteins, 
however the function of individual Csm proteins is unknown. The evidence that Type III-A systems 
target DNA remains indirect and relies on the experimental observation that Type III-A RNP complex 
from Staphylococcus epidermidis (SeCsm) limits plasmid conjugation and transformation in vivo, but 
the DNA degradation has not been demonstrated directly (Marraffini and Sontheimer, 2008, 2010). The 
Csm complex from the archaeon Sulfolobus solfataricus (SsCsm) binds dsDNA, however, it shows no 
crRNA-dependent nuclease activity in vitro (Rouillon et al., 2013). Thus, while the RNA cleavage 
activity of the Cmr complex has been characterised in vitro, the DNA degradation activity of the Type 
III-A Csm complex has yet to be demonstrated. The Csm complex so far remains the only CRISPR-Cas 
effector complex, for which the function is not yet reconstituted in vitro. Here we aimed to establish the 
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composition and mechanism of the Csm complex for Type III-A system Streptococcus thermophilus 
(St).  
 
Results 
Type III-A CRISPR-Cas loci in S. thermophilus 
S. thermophilus strain DGCC8004 that was selected for further experimental characterization carries 13 
spacers in its Type III-A CRISPR2 array (Figure 1A and S1). This strain also contains a Type II 
CRISPR1 system that is present in other S. thermophilus strains (unpublished data). In the CRISPR2 
locus of DGCC8004 the 36-nt repeat sequences, that are partially palindromic, are conserved with the 
exception of the two terminal repeats (Figure 1A). An A+T rich 100-bp leader sequence is located 
upstream of the CRISPR2 array. 
DGCC8004 CRISPR2 (Type III-A) spacers range in size between 34 and 43 nt, but 36-nt spacers are 
the most abundant. In total, 38 XQLTXH VSDFHUV ZHUH LGHQWL¿HG among CRISPR2-positive 
S. thermophilus strains and a majority (20 out of 38) of these spacer sequences have matches 
(protospacers) in S. thermophilus DNA phage sequences, although phage interference for the 
S. thermophilus CRISPR2 locus has not yet been demonstrated. Analysis of the sequences located 
immediately upstream and downstream of these protospacers failed to identify any consensus sequence 
(data not shown) as a putative PAM, either due to the relatively small number of protospacers or RNA 
targeting that is often PAM-independent (Hale et al., 2009). In DGCC8004, although no CRISPR2 
spacer gives perfect identity with currently known sequences, 6 spacers out of 13 (S3, S4, S6, S8, S12 
and S13) show strong sequence similarity with S. thermophilus DNA phages (at least 94% identity over 
at least 80% of spacer length). Interestingly, all phage matching protospacers were selected from the 
template strand. For instance, the 36-nt spacer S3 matches 34 nt of a protospacer in the S. thermophilus 
phage O1205 genome (Figure 1B). A corresponding crRNA would match the template DNA strand of 
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the protospacer S3, and will pair with the target sequence on the coding strand of phage DNA or the 
respective mRNA sequence. If crRNA processing in the S. thermophilus Type III-A locus is similar to 
that in S. epidermidis (Hatoum-Aslan et al., 2011; Hatoum-Aslan et al., 2014; Hatoum-Aslan et al., 
2013) WKH UHVXOWLQJ FU51$ ¶-handle in the mature crRNA will be non-complementary to the 
protospacer S3 ¶-flank in the phage DNA coding strand or mRNA (Figure 1B). In the S. epidermidis 
Type III-A system, which limits the spreading of plasmid DNA, the crRNA/target DNA non-
complementarity outside of the spacer sequence plays a key role in invading DNA silencing and self vs 
non-self DNA discrimination (Marraffini and Sontheimer, 2010). Taking these elements into 
consideration, crRNA encoded by the spacer S3 was selected as the guide, and a complementary 
protospacer sequence as the NA target (DNA or RNA) (Figure 1B). 
 
Cloning, expression and isolation of the S. thermophilus DGCC8004 Type III-A effector complex  
In order to isolate the Type III-A RNP effector complex (StCsm) of the DGCC8004 we split CRISPR2 
locus into the three fragments and cloned them into three compatible vectors (Figure 1C). Plasmid 
pCas/Csm contained a cassette including all the cas/csm genes (except cas1 and cas2), while plasmid 
pCRISPR_S3 carried 4 identical tandem copies of the repeat-spacer S3 unit flanked by the leader 
sequence and the terminal repeat. Plasmids pCsm2-Tag or pCsm3-Tag carried a StrepII-tagged variant 
of csm2 or csm3 genes, respectively. Next, all three plasmids were co-expressed in E. coli BL21 (DE3) 
and tagged Csm2 or Csm3 proteins were isolated by subsequent Strep-chelating affinity and size 
exclusion chromatography. 
Strep-tagged Csm2 or Csm3 proteins pull-downed from E. coli lysates co-purified with other Csm/Cas 
proteins suggesting the presence of a Csm complex (Figure 1D). Csm complexes isolated via N-
terminus Strep-tagged Csm2 (Csm2_StrepN) and the N-terminus Strep-tagged Csm3 proteins 
(Csm3_StrepN) were subjected to further characterization. SDS-PAGE of these complexes revealed six 
bands that matched the individual Cas proteins Cas6, Cas10, Csm2, Csm3, Csm4 and Csm5 
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(Figure 1D). The identity of proteins in these Csm complexes ZDV FRQ¿UPHG E\ PDVV VSHFWURPHWU\
(MS) analysis (Tables S1 and S2). 
We next examined the Csm complexes for the presence of NA using basic phenol-chloroform 
extraction followed by RNase I or DNase I digestion. Denaturing PAGE analysis revealed that ~70-nt 
and ~40-nt RNA molecules co-purified with the Csm3_StrepN and Csm2_StrepN pulled-down Csm 
complexes, respectively (Figure 1E). The complex isolated via Csm2_StrepN subunit also contained 
~10% of the ~70-nt RNA. When subjected to RNase I protection assay the RNA in the complexes 
showed no visible degradation, indicating that the RNA is tightly bound and protected along its entire 
length (data not shown). 
 
Characterization of the crRNA  
We used denaturing RNA chromatography in conjunction with electrospray ionization mass 
spectrometry (ESI-MS) to analyse the crRNA sequence and determine the chemical nature of the ¶-
and ¶-termini of crRNAs co-purified with both Csm complexes. Denaturing ion pair reverse phase 
chromatography was used to rapidly purify the crRNA directly from the Csm complexes. The crRNA 
isolated from the Csm3_StrepN pull-down complex revealed a single crRNA with a retention time 
consistent with an approximate length of 70 nt (Figure 1F). The crRNA isolated from Csm2_StrepN 
pull-down complex revealed the presence of an additional crRNA, with a retention time consistent with 
an approximate length of 40 nt (Figure 1G). Purified crRNAs were further analyzed using ESI-MS to 
obtain the accurate intact masses. A molecular weight of 22 998.5 Da was obtained for RNA isolated 
from Csm3 and 12 602.2 Da for RNA isolated from Csm2 pull-downs, respectively. Csm2 pull-down 
also contained a minor component, with a molecular weight of 12 907.3 Da (data not shown). In 
addition, ESI MS/MS was also used to analyse the oligoribonucleotide fragments generated from 
RNase A/T1 digestion of the crRNAs (Figure S2). In conjunction with the intact mass analysis, these 
results revealed a 72-nt crRNA in the complex isolated via Csm3 (further termed Csm-72 according to 
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the length of crRNA) and a 40-nt crRNA in the complex isolated via Csm2 (further termed Csm-40 
complex). The MS analysis of the 72-nt crRNA is consistent with the pre-CRISPR cleavage at the base 
of the CRISPR RNA hairpin to yield a 8-QW¶-handle, a 36-nt spacer and a 28-QW¶-KDQGOHZLWK¶-OH 
DQG ¶-P, and could represent unmaturated crRNA intermediate (Figure 1F) similar to that of Type 
III-A and III-B CRISPR-Cas systems (Hale et al., 2009; Hatoum-Aslan et al., 2013). Further 
YHULILFDWLRQRIWKH¶-P termini was obtained upon acid treatment of the 72-nt crRNA where no change 
in mass was observed using ESI-MS. Likewise, the MS analysis of the 40-nt crRNA in the Csm-40 
complex revealed an 8-QW¶-handle and a 32-QWVSDFHUZLWK¶-2+DQG¶-OH that would correspond to 
the matured crRNA (Figure 1G). The difference LQ WKH FKHPLFDO QDWXUH RI WKH ƍ-end between 
intermediate aQGPDWXUHFU51$VVXJJHVWVWKDWSULPDU\SURFHVVLQJDQG¿QDOPDWXUDWLRQDUHDFKLHYHGE\
distinct catalytic mechanisms as proposed by Hatoum-Aslan for the S. epidermidis model system 
(Hatoum-Aslan et al., 2011). 
 
Composition and shape of the Csm complex 
Evaluation of the complex composition by densitometric analysis of the SDS gels suggests the 
Cas101:Csm26:Csm310:Csm41:Csm50.14 stoichiometry for Csm-72, and the 
Cas60.10:Cas101:Csm23:Csm35:Csm41:Csm51 stoichiometry for Csm-40. Fraction numbers for Cas6 and 
Csm5 proteins are presumably due to the weak transient interactions of these proteins in the respective 
complexes. Protein subunits that are involved in pre-crRNA processing, e.g. Cas6, would not 
necessarily occur in stoichiometric amounts in the purified effector complex. 
We also performed the small angle X-ray scattering (SAXS) measurements in order to characterize the 
molecular mass/shape of both Csm-40 and Csm-72 effector complexes in solution. Mw values obtained 
using SAXS are in agreement both with DLS and gel-filtration data (Table S3). Taken together these 
data are consistent with the stoichiometry Cas101:Csm26:Csm310:Csm41:crRNA1 (calculated Mw 486.2 
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kDa including the 72-nt crRNA) for Csm-72 and Cas101:Csm23:Csm35:Csm41:Csm51:crRNA1 
(calculated Mw 344.8 kDa including 40-nt crRNA) for Csm-40. 
SAXS measurements revealed that the Csm-40 complex in solution has elongated and slightly twisted 
shape. The maximal interatomic distance (Dmax) of the complex estimated from SAXS data is 215 Å, 
whereas its diameter is 75-80 Å (Table S4). The shape of this effector complex (Figure 1H) is very 
similar to the electron microscope structure of Cmr complexes from Thermus thermophilus (Staals et 
al., 2013), Pyrococcus furiosus (Spilman et al., 2013) and Cascade from E. coli (Wiedenheft et al., 
2011) (Figure S3E). The Csm-72 complex with Dmax of 280 Å (Table S4) is significantly more 
elongated than the Csm-40 complex (Figure 1H). The lowest normalized spatial discrepancy was 
obtained for the end-to-end superimposition of the Csm-40 and Csm-72 models (Figure 1H). 
 
Nucleic acid specificity of the Type III-A StCsm complex 
In the CRISPR2 locus of DGCC8004, 34 out of 36 nt of the spacer S3 match a sequence present in the 
genome of S. thermophilus phage O1205. Therefore, to probe the functional activity of the Csm-40 
complex we first designed DNA and RNA substrates that are fully complementary to the 32-nt crRNA 
encoded by spacer S3 and that carry phage O1205-flanking sequence. These flanking sequences lack 
complementarity to the 8-QW ¶-handle of the crRNA identified in the Csm-40/Csm-72 complexes 
(Figure 2A and Table S5). For binding analysis DNA or RNA substrates were ¶-end radioactively 
labeled and the Csm-40 complex binding was evaluated by an electrophoretic mobility shift assay 
(EMSA) in the absence of any divalent metal (Me2+) ions. Csm-40 showed weak affinity for 
oligoduplex S3/1 DNA/DNA and DNA/RNA substrates since binding was observed only at high (100-
300 nM) complex concentrations. Single-stranded S3/1 DNA (ssDNA) was bound to Csm-40 with an 
intermediate affinity (Kd | 30 nM), whereas a single-stranded S3/1 RNA (ssRNA) showed high affinity 
binding (Kd | 0.3 nM) (Figure 2B). Binding competition experiments with various nucleic acids 
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supported the single-stranded RNA specificity for the Csm-40 complex (Figure 2C). Cleavage data 
correlated with the binding affinity: S3/1 DNA/DNA, DNA/RNA and ssDNA are refractory to 
cleavage, whereas S3/1 ssRNA complementary to the crRNA is cut by Csm-40 in the presence of Mg2+ 
ions (Figure 2D). RNase activity of Csm-40 complex requires Mg2+ or other divalent metal ions (Mn2+, 
Ca2+, Zn2+, Ni2+ or Cu2+) and is inhibited by EDTA (Figure S4E). 
Surprisingly, Csm-40 cuts the S3/1 RNA target at 5 sites regularly spaced by 6-nt intervals to produce 
48-, 42-, 36-, 30- and 24-nt products, respectively (Figures 2D, 2E). The sequence complementarity 
between the crRNA in the complex and the RNA target is a key pre-requisite for the cleavage: a non-
specific RNA (Figure 2E, bottom) was resistant to Csm-40. The Csm-40 cleavage pattern of the ¶-
labeled S3/1 RNA substrate GLIIHUVIURPWKDWRI WKH¶-labeled variant. While WKH¶-labeled substrate 
cleavage produces 48-, 42-, 36-, 30- and 24-nt products, short degradation products of 21, 27, and 33 nt 
(1 nt shift is due to an additional nucleotide added during WKH ¶-labeling) are visible on the gel 
(Figures 2D, 2E). Taken together, cleavage data for WKH¶- DQG¶-end labeled RNA substrates suggest 
that Csm-40 cuts the RNA molecule LQLWLDOO\DW LWV¶-end and endonucleolytic degradation is further 
extended towards the ¶-end with 6-nt increments. 
The Csm-72 complex carrying a 72-nt crRNA (8-QW¶-handle plus 36 nt of the spacer S3 and 28 nt of 
the ¶-handle, Figure S4A) showed ~ 30-fold weaker binding affinity (Kd | 10 nM) to S3/1 RNA in 
comparison to the Csm-40 (Figure S4B). Nevertheless, similarly to the Csm-40 complex, in the 
presence of Mg2+ ions Csm-72 cleaved S3/1 RNA, albeit at a decreased rate which may correlate with 
its weaker binding affinity (Figure S4C). The ¶- DQG¶-labeled S3/1 RNA cleavage pattern is identical 
to that of Csm-40 (Figures S4C, S4D and data not shown). Like the Csm-40 complex, Csm-72 showed 
no cleavage of S3/1 ssDNA, DNA/DNA or DNA/RNA substrates (data not shown). The heterogeneous 
Csm complex isolated from the E.coli host carrying the wt CRISPR array containing 13 spacers 
produces RNA cleavage products identical to those of the homogenous StCsm (Figure S4F). Taken 
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together, these data unambiguously demonstrate that Csm-40 and Csm-72 complexes in vitro target 
RNA but not DNA, and cut RNA at multiple sites regularly spaced by 6-nt intervals. 
 
Reprogramming of the StCsm complex 
To demonstrate that the Type III-A StCsm complex can be reprogrammed to cut a desired RNA 
sequence in vitro we designed and isolated Csm complexes loaded with crRNA(+Tc) and crRNA(-Tc) 
targeting, respectively, the 68 nt sense(+) and anti-sense(-) mRNA fragments obtained by in vitro 
transcription of the tetracycline (Tc) resistance protein gene in the pBR322 plasmid (nt 851-886) 
(Figure S5A and Table S5). Both Csm-40 and Csm-72 complexes guided by the crRNA(+Tc) sliced the 
complementary sense RNA fragment but not the antisense RNA sequence (Figure S5B). On the other 
hand, Csm-40 and Csm-72 complexes guided by the crRNA(-Tc) cleaved antisense RNA but not a 
sense Tc mRNA fragment (Figure S5B). In both cases target RNA was cleaved at multiple sites 
regularly spaced by 6-nt intervals (Figure S5C). 
 
Target RNA determinants for cleavage by crRNA-guided Csm complex 
We examined further whether the nucleotide context downstream or upstream of the protospacer 
sequence modulates RNA cleavage by the Csm complexes. To this end, we designed the S3/2 RNA 
substrate in which the flanking regions originating from O1205 phage DNA in the S3/1 substrate are 
replaced by different nucleotide stretches that are non-FRPSOHPHQWDU\WRWKH¶-handle of crRNA in the 
Csm-40 and Csm-72 complexes, and to the ¶-handle in the Csm-72 complex. RNA binding and 
cleavage data showed that despite differences in the nucleotide context of flanking sequences in the 
S3/1 and S3/2 substrates, cleavage patterns for the Csm-40 and Csm-72 complexes are nearly identical, 
except for an extra 18-nt product for the Csm-72 (Figure S4C). 
Next, we addressed the question whether the base-pairing between the flanking sequences of the RNA 
target DQG¶- and 3- handles of crRNA in the Csm-40 and Csm-72 complexes affect either the cleavage 
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efficiency or pattern. We designed S3/3, S3/4, and S3/5 RNA substrates that contain flanking 
sequences complementary WRWKH¶-handle (40- or 72-QWFU51$¶-handle (72-QWFU51$RUERWK¶- 
DQG ¶-handles in 72 nt-crRNA, respectively (Figure S5A and Table S5). The cleavage analysis 
revealed that base-pairing between the 8-QW¶-handle RIFU51$DQGWKH¶-flanking sequence had no 
effect on the cleavage pattern of the Csm-40 and Csm-72 complexes. Indeed, the S3/3 substrate is 
cleaved with the same 6-nt step by Csm-40, suggesting that the non-complementarity of the flanking 
sequences is not a necessary pre-requisite for cleavage by the Csm complex (Figure S5). Surprisingly, 
for the Csm-72 complex extension of the base-SDLULQJEHWZHHQWKH¶-handle of the 72-nt crRNA and 
WKHSURWRVSDFHU¶-flanking sequence in S3/5 RNA substrate results in target RNA cleavage outside the 
protospacer yielding 12- and 6-nt cleavage products (Figure 3). Moreover, the S3/6 substrate, which 
has extended complementarity EHWZHHQ FU51$ ¶-KDQGOH DQG ¶-flanking sequence was cleaved at 
multiple positions along the full length of RNA duplex, except for the region complementary to the 
crRNA ¶-handle (Figure 3). The cleavage at 18 and 12 nt outside the protospacer was also detected for 
the Csm-40 complex on S3/4 and S3/5 RNA substrates (Figure S6). The 40-nt crRNA present in the 
Csm-40 complex lacks tKH ¶-handle DQG WKHUHIRUH FDQQRW IRUP 51$ GXSOH[ ZLWK WKH ¶-flanking 
sequence in the S3/5 and S3/6 RNA substrates. However, the Csm-40 complex preparation still 
contains ~ 10% of unmatured 72-nt crRNA, and this heterogeneity results in the extra cleavage outside 
the protospacer (Figure S6C). 
To interrogate the importance of base-pairing within the protospacer region for target RNA cleavage 
we designed a set of RNA substrates harboring two adjacent nucleotide mutations in the spacer region 
(substrates S3/7, S3/8 and S3/9, see Figure S6A and Table S5). Two nucleotide mismatches in these 
substrates did not compromise RNA cleavage by the Csm-40 (Figure S6) and Csm-72 complexes (data 
not shown), suggesting that the StCsm complex tolerates at least 2 contiguous mismatches in the 
protospacer region homologous to the crRNA. 
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To explore whether ¶- or ¶-ends of the target RNA are important for cleavage by the Csm-40 
complex, we designed a set of truncated RNA substrates. In S3/10, S3/14 and S3/12 RNA substrates 
unpaLUHGÀDSs DWWKH¶-¶- or both ends of the target RNA were truncated, while in S3/11 and S11/13 
substrates the truncations extend into the region complementary to crRNA (Figure 4A). Binding 
affinity for the most of truncated substrates was not compromised (Figure 4B) and target RNA 
cleavage occurred at multiple sites spaced by 6-nt intervals at conserved protospacer positions 
(Figure 4C). Truncations extending into the protospacer region (S3/11 and S3/13) showed decreased 
binding and reduced cleavage rates. This could be a result of the decreased duplex stability, however 
WKHUROHRIWKH³VHHG´VHTXHQFHFDQQRWEHH[FOXGHG. Importantly, for all RNA substrates the cleavage 
sites were located at a fixed distance with respect to the conserved ¶-handle of crRNA (Figure 4C). 
 
Identification of the ribonuclease subunit in the StCsm complex 
Regularly spaced cleavage pattern of the RNA target (Figures 2-4, S4, S6) implies the presence of 
multiple cleavage modules in the Csm complex. According to the densitometric analysis, 3 Csm2 and 5 
Csm3 subunits are identified in the Csm-40 complex, while 6 Csm2 and 10 Csm3 subunits are present 
in the Csm-72 complex. Multiple copies of the Csm2 and Csm3 proteins in the Csm complexes make 
them prime candidates for catalytic subunits. StCsm2 is a small (121 aa) Į-helical protein of unknown 
structure. StCsm3 (220 aa) contain a conserved (RRM core and is fairly closely related (~35% 
sequence identity) to Methanopyrus kandleri Csm3, whose crystal structure has been solved recently 
(Hrle et al., 2013). We reasoned that, since the catalytic activity of the StCsm complex requires the 
presence of Me2+ ions, the active site is likely to contain one or more acidic residues. We inspected 
multiple sequence alignments of both Csm2 and Csm3 protein families for conserved aspartic or 
glutamic residues. We did not find any promising candidates in StCsm2, but identified several, 
including D33, D100, E119, E123 and E139 in StCsm3 (Figure 5A). To probe the role of these 
conserved negatively charged Csm3 residues we constructed mutants having one residue at a time 
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replaced with alanine. We also constructed the H19A mutant, since it was shown that the 
corresponding mutation (R21A) in M. kandleri Csm3 abolished binding of single-stranded RNA (Hrle 
et al., 2013). We expressed each mutant in the context of other StCsm/Cas proteins and analysed the 
cleavage activity of the StCsm-40 complex containing mutant Csm3 subunits. StCsm3 H19A, D100A, 
E119A, E123A and E139A mutants did not compromise RNA binding, RNP complex composition or 
cleavage activity of Csm-40 complex (Figure 5B-5F). However, the D33A mutant impaired Csm-40 
RNA cleavage (Figure 5D, 5F) without affecting RNA binding (Figure 5D). Taken together these data 
demonstrate that Csm3 is a RNase, which cuts RNA producing multiple cleavage patterns spaced by 
regular 6-nt intervals, and that the D33 residue is part of the catalytic/metal-chelating site. StCsm3 
structural model based on the homologous structure of M. kandleri Csm3 is in good agreement with the 
identified role for this residue (Figures S7A). D33 belongs to the highly conserved surface patch that 
extends from the RRM core LQWR WKH ³OLG´ subdomain (Figure S7B). Part of this surface patch is 
positively charged, supporting the idea that it represents an RNA-binding site (Figure S7C). 
 
In vivo RNA targeting by the StCsm complex  
To demonstrate that the StCsm complex could target RNA in vivo, we employed the MS2 phage 
restriction assay. MS2 is a lytic single-stranded RNA coliphage which infects E. coli host via fertility 
(F) pilus. MS2 phage is a favorable model to investigate RNA targeting by the CRISPR-Cas system in 
vivo as no DNA intermediates are formed during the life cycle of this phage (Olsthoorn and van Duin, 
2011). To engineer the MS2 phage targeting heterologous host, E.coli NovaBlue (DE3, F+) strain has 
been transformed by two compatible plasmids: i) pCRISPR_MS2 plasmid bearing the synthetic 
CRISPR array of five repeats interspaced by four 36-nt spacers targeting the mat, lys, cp, and rep MS2 
RNA sequences, and ii) pCsm/Cas plasmid for expression of Cas/Csm proteins (Figure 6). The phage 
targeting and control E. coli strains were plated and infected with series of dilutions of MS2 using drop 
plaque assay. The assay revealed that E. coli strain expressing wt Csm and MS2 targeting crRNAs 
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restricts the phage at least 1000-fold in respect to the control cells. Importantly, no MS2 phage 
resistance has been observed in the strain expressing the non-targeting crRNA or the cleavage deficient 
Csm3 variant. Taken together these data demonstrate that the StCsm complex in vivo convey resistance 
to RNA phage in the heterologous E. coli host. 
 
Discussion 
Here we aimed to establish the NA specificity and mechanism for the Type III-A CRISPR-Cas system 
of Streptococcus thermophilus. In sharp contrast to other CRISPR-Cas subtypes, the functional activity 
of Type III-A system so far has not been reconstituted in vitro. Cas/Csm proteins in the Type III-A 
CRISPR locus of the S. thermophilus DGCC8004 are homologous to those of in S. thermophilus 
DGCC7710 and LMD-9, and show more distant but significant similarities to Cas/Csm proteins in 
L. lactis, E. italicus and S. epidermidis (Marraffini and Sontheimer, 2008; Millen et al., 2012) 
(Figure S1). 
Csm complexes of S. thermophilus 
We have expressed the Type III-A CRISPR-Cas locus of the DGCC8004 in E. coli and isolated two 
RNP complexes termed Csm-40 and Csm-72. Both complexes share a conserved set of Cas10, Csm2, 
Csm3 and Csm4 proteins. In addition to this core, the Csm-40 also contains the Csm5 protein. Two 
distinct crRNAs of 72- and 40-nt co-purify with Csm-40 and Csm-72 complexes isolated from the 
heterologous E. coli host. The 72-nt crRNA comprised of an 8-QW¶-handle, a 36-nt spacer and a 28-nt 
¶-handle would result from the pre-crRNA cleavage between 28 and 29 nt within the conserved repeat 
region presumably by the Cas6 nuclease similarly to the III-B CRISPR-Cas system (Carte et al., 2008). 
The shorter 40-nt crRNA co-purified with the Csm-40 complex of S. thermophilus contains the 
conserved 8-QW ¶-handle and 32-nt spacer indicating that the 72-nt crRNA intermediate underwent 
IXUWKHU¶-end processing to produce a mature 40-nt crRNA that lacks WKH¶-handle and 4 nt within the 
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spacer region (Figure 7). The RNAse involved in the 72 nt crRNA intermediate  maturation still has to 
be identified, however the Csm5 protein which is absent in Csm-72 but is present in Csm-40 could be a 
possible candidate. Indeed, csm5 gene deletion in DGCC8004 produces only unmatured Csm-72 
complexes (G.T., M.K., Irmantas Mogila, unpublished data). 
The crRNA processing and maturation pathway in the S. thermophilus Type III-A system (Figure 7) 
shows striking similarity to that in S. epidermidis. First, the SeCsm complex includes the same set of 
Cas10, Csm2, Csm3, Csm4 and Csm5 proteins as the StCsm-40. Furthermore, in S. epidermidis, the 
primary processing by Cas6 produces a 71-nt crRNA intermediate, that is subjected to further 
endonucleolytic processing at the 3ƍ end (Hatoum-Aslan et al., 2011; Hatoum-Aslan et al., 2014). 
StCsm complex cuts RNA producing a regular cleavage pattern 
The Csm complexes of S. epidermidis and S. solfataricus have been reconstituted and isolated, 
however NA cleavage activity has not been reported so far. In vivo studies in S. epidermidis suggested 
that the Type III-A SeCsm RNP complex targets DNA (Marraffini and Sontheimer, 2008) in a PAM-
independent manner and prevents autoimmunity by checking the complementarity between the crRNA 
ƍ-handle aQG WKHƍ-flanking sequence in the vicinity of the protospacer (Marraffini and Sontheimer, 
2010). In contrast to these data we found that the StCsm-40 and StCsm-72 complexes bind ssRNA with 
high affinity and cut a ssRNA target in a PAM-independent manner in the presence of Me2+ ions, 
producing a regular 6-nt cleavage pattern in the protospacer region (Figures 2D and S4C-S4E). In this 
respect the Type III-A StCsm complex resembles the RNA-targeting Type III-B Cmr-complexes 
PfCmr, SsCmr and TtCmr (Hale et al., 2009; Staals et al., 2013; Zhang et al., 2012) (Figure 7) rather 
than DNA targeting Type I and II complexes. By targeting RNA rather than DNA StCsm complex 
avoids autoimmunity. We further show that the nucleotide context and non-complementarity outside 
the protospacer have no effect on the target RNA cleavage, demonstrating that PAM or unpaired 
flanking sequences of the protospacer are not required for cleavage by the StCsm (Figure S6). The 
complementarity of the protospacer is the only pre-requisite for the StCsm cleavage: non-matching 
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RNA is not cleaved, however in the complimentary protospacer S3 two contiguous mismatches and 
end truncations are tolerated by StCsm (Figure S6). The differences in the cleavage pDWWHUQVRIWKH¶- 
DQG ¶-labeled RNAs (Figure 2D) imply that cleavage first occurred DW ¶-end of the target RNA. 
However, it remains to be established whether the observed cleavage directionality is dictated by the 
³VHHG´ VHTXHQFHdirectionality of the crRNA:target RNA duplex formation or nucleotide context-
dependent cleavage rate differences. 
Strikingly, we found that for the Csm-72 complex the target RNA is being cleaved at regular 6-nt 
intervals outside the protospacer if it retains base complementarity to the crRNA ¶-handle. Such 
regularly spaced cleavage pattern of the RNA target (Figures 2-4, S4 and S6) implies the presence of 
multiple cleavage modules in the Csm complex. The major difference between the Csm-40 and Csm-72 
complexes is the number of Csm2 and Csm3 subunits. The Csm-40 contains 3 Csm2 and 5 Csm3 
subunits while Csm-72 contains 6 Csm2 and 10 Csm3 subunits (Figure 1D). The size of the complexes 
determined by SAXS correlates with the different stoichiometry of Csm-40 and Csm-72. Indeed, both 
complexes show a slightly twisted elongated shape but the Csm-72 is significantly more elongated than 
Csm-40 complex (Figure 1H). Taken together these data suggest that the longer unmatured 72-nt 
crRNA intermediate in the Csm-72 complex binds additional copies of Csm2 and Csm3 subunits into a 
RNP filament (Figure 7). 
Csm3 is a RNAse subunit in the StCsm complex 
Computational analysis revealed that StCsm3 has a conserved RRM core and is fairly closely related 
(~35% sequence identity) to M. kandleri Csm3 (Hrle et al., 2013). StCsm3 displays close structural 
similarity to MkCsm3, in particular the RRM-core and insertions into RRM-FRUH WKDW IRUP WKH³OLG´
subdomain (Figure S7A). In contrast, StCsm3 lacks both the N-terminal zinc binding domain and the 
C-terminal helical domain, making its structure more compact compared to that of MkCsm3. Thus, 
StCsm3 may be considered as a trimmed-down version of MkCsm3. Guided by the multiple sequence 
alignment and homology model of StCsm3, we selected candidate active site/metal chelating residues 
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of Csm3 and subjected them to alanine mutagenesis. We showed that the highly conserved D33 residue 
of the StCsm3 is critical for the RNA cleavage activity of the Csm complex, demonstrating that Csm3 
is a RNase in the StCsm and could be universal in all Type III-A CRISPR/Cas systems (Figure 5). 
Implications for other RNA-targeting CRISPR systems 
Taken together, our data indicate that the StCsm complex is specific for the RNA and cuts it in a PAM-
independent manner producing a regular 6-nt cleavage pattern. Furthermore, we demonstrate that the 
Csm3 protein, which is present in Csm-40 and Csm-72 complexes in multiple copies, acts as a RNase 
responsible for the target RNA cleavage. In this respect the Type III-A Csm complex of 
S. thermophilus closely resembles the RNA targeting Type III-B Cmr complex of T. thermophilus 
(TtCmr complex) that also produces a regular 6-nt cleavage pattern (Staals et al., 2013). The RNA 
degrading subunit in the Type III-B Cmr-module remains to be identified. Although there is currently 
no experimental evidence, Staals et al. suggested that Cmr4 could fulfill this role (Staals et al., 2013). 
Indeed, clustering of Csm3 and Cmr4 homologs by sequence similarity revealed that they form two 
related but separate groups (Figure S7D). On the other hand, neither Csm3 nor Cmr4 families are 
homogenous. They are comprised of sequence clusters of various sizes. StCsm3 is a member of a large 
representative group of Csm3 homologs that includes those from S. epidermidis, L. lactis and 
M. kandleri. Another large, but more loosely connected group does not have proteins from 
experimentally characterized systems, except for the Csm complex from S. solfataricus. Sso1425 and 
Sso1426, two of its Csm3-like proteins (Makarova et al., 2011a), are members of this group albeit they 
are non-typical. The Cmr4 family appears even more fragmented than Csm3. Cmr4 proteins of 
experimentally characterized III-B systems from T. thermophilus and P. furiosus represent one of the 
larger clusters, while Cmr4 from S. solfataricus is a non-typical outlier. Indeed, biochemical 
characterisation revealed that PfCmr and TtCmr RNA cleavage mechanism are similar and follow a 3¶- 
or 5-¶ ruler mechanism, respectively (Hale et al., 2009; Staals et al., 2013). Meanwhile, SsCmr 
endonucleolytically cleaves both target RNA and crRNA at UA dinucleotides (Zhang et al., 2012). 
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Therefore, it would not be surprising if members of other, so far experimentally uncharacterized groups 
were part of Cmr complexes with somewhat different properties. 
Naturally, we were curious if Csm3 and Cmr4 proteins may have similarly organized active site. The 
aligned sequences of Csm3 and Cmr4 subunits from characterized systems revealed that sequences of 
both families have Asp in the corresponding positions, suggesting similar active sites (Figure 5A). The 
exception is Sso1426. This is quite surprising, considering the composition of the S. solfataricus Csm 
complex. Four copies of Sso1426 were found to be present within the complex suggesting that this 
subunit might play a role of the Csm3 (Rouillon et al., 2013). In contrast, another Csm3-like protein 
Sso1425 does have the D33 counterpart suggesting it can cleave ssRNA. However, only a single copy 
of Sso1425 was found in the S. solfataricus complex. Taken together, these data suggest that Csm-
modules in S. thermophilus and S. solfataricus have different architectures and RNA cleavage 
mechanisms. 
Concluding remarks 
We show here for the first time that the Csm effector complex of the S. thermophilus Type III-A 
system targets RNA and establish the mechanism of RNA cleavage. We demonstrate that in the Type 
III-A effector complex Cas/Csm proteins assemble into an RNP filament (Figure 7) that contains 
multiple copies of Csm2 and Csm3 proteins. Furthermore, we provide evidence that the Csm3 subunit 
acts as a RNase that cleaves target RNA at multiple sites spaced by regular 6-nt intervals (Figure 7). 
The number of cleavage sites number correlates with the number of Csm3 subunits in the Csm effector 
complex. Easy programmability of the Type III-A StCsm complex by custom crRNAs (Figure S5), 
paves the way for the development of novel molecular tools for RNA interference. 
RNA cleavage specificity established here for the StCsm complex in vitro, is supported by in vivo 
experiments of the MS2 RNA phage interference in the heterologous E.coli host (Figure 6). It remains 
to be established whether RNA silencing by the StCsm complex can contribute to the DNA phage 
interference in the S. thermophilus host. Transcription-dependent DNA targeting mechanism has been 
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proposed recently for the Type III-B CRISPR-Cmr system (Deng et al., 2013), however it yet has to be 
demonstrated for S. thermophilus and other Type III-A systems. 
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Experimental procedures 
Expression and isolation of Csm complexes 
Sequenced CRISPR2 locus of S. thermophilus DGCC8004 was deposited in GenBank (accession 
number KM222358). Heterologous E. coli BL21(DE3) cells producing the Strep-tagged Csm 
complexes were engineered and cultivated as described in the Supplemental Experimental Procedures. 
Csm-40 and Csm-72 complexes were isolated by subsequent Strep-chelating affinity and size exclusion 
chromatography steps (Supplemental Experimental Procedures). 
Bioinformatic analysis and mutagenesis of Csm3 
Putative active site residues of Csm3 were identified from multiple alignment of Csm3/Cmr4 (see 
Supplemental Experimental Procedures for details). Csm3 mutants were constructed using quick 
change mutagenesis and purified as described in Supplemental Experimental Procedures. 
Extraction, HPLC purification and ESI-MS analysis of crRNA  
NAs co-purified with Csm-40 and Csm-72 were isolated using phenol:chloroform:isoamylalcohol 
(25:24:1, v/v/v) extraction and precipitated with isopropanol. Purified NAs were incubated with 0.8 U 
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DNase I or 8 U RNase I (Thermo Scientific) for 30 min at 37°C. NAs were separated on a denaturing 
15% polyacrylamide gel (PAAG) and visualised by SybrGold (Invitrogen) staining. 
Ion-pair reversed-phased-HPLC purified crRNA architecture was determined using denaturing RNA 
chromatography in conjunction with electrospray ionization mass spectrometry (ESI-MS) as described 
in (Sinkunas et al., 2013) and Supplemental Experimental Procedures. 
Small angle X-ray scattering (SAXS) experiments 
SAXS data for Csm-40 and Csm-72 were collected at P12 EMBL beam-line at PETRAIII storage ring 
of DESY synchrotron in Hamburg (Germany). Csm-40 and Csm-72 complexes were measured in 3 
different concentrations in buffer containing 20 mM Tris-HCl (pH 8.5 at 25°C), 0.5 M NaCl, 1mM 
EDTA and 7 mM 2-mercaptoethanol. Data collection, processing and ab initio shape modeling details 
are presented in Table S4 and Figure S3. 
DNA and RNA substrates 
Synthetic oligodeoxynucleotides were purchased from Metabion. All RNA substrates were obtained by 
in vitro transcription using TranscriptAid T7 High Yield Transcription Kit (Thermo Scientific). A full 
description of all the DNA and RNA substrates is provided in the Table S5. DNA and RNA substrates 
were either ¶-ODEHOHGZLWK>Ȗ32P] $73DQG31.RU¶-labeled with [D32P] cordycepin-¶-triphospate 
3HUNLQ(OPHUDQGSRO\$SRO\PHUDVH/LIH7HFKQRORJLHVIROORZHGE\GHQDWXULQJJHOSXUL¿FDWLRQ. 
Electrophoretic mobility shift assay  
Binding assays were performed by incubating different amounts of Csm complexes with 0.5 nM of 32P-
ƍ-labeled NA in the Binding buffer (40 mM Tris, 20 mM acetic acid (pH 8.4 at 25qC), 1 mM EDTA, 
0.1 mg/ml BSA, 10% (v/v) glycerol). All reactions were incubated for 15 min at room temperature 
prior to electrophoresis on native 8% (w/v) PAAG. Electrophoresis was carried out at room 
temperature for 3 h at 6 V/cm using 40 mM Tris, 20 mM acetic acid (pH 8.4 at 25qC), 0.1 mM EDTA 
as the running buffer. Gels were dried and visualized using a FLA-5100 phosphorimager (Fujifilm). 
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The Kd for NA binding by Csm-72 and Csm-40 was evaluated assuming the complex concentration at 
which half of the substrate is bound as a rough estimate of Kd value. For binding competition assay 0.5 
nM 32P-labelled S3/1 RNA was mixed with 0.5-5000 nM of unlabelled competitor NA and 0.3 nM 
StCsm-40,and analysed by EMSA. 
Cleavage assay  
The Csm-40 reactions were performed at 25°C and contained 20 nM of ¶- RU ¶-radiolabeled NA 
(Table S5) and 62.5 nM (unless stated otherwise) complex in the Reaction buffer (33 mM Tris-acetate 
(pH 7.9 at 25qC), 66 mM K-acetate, 0.1 mg/ml BSA and 10 mM Mg-acetate). Csm-72 reactions were 
performed in the same Reaction buffer at 37°C and contained 20 nM of radiolabeled NA and 125 nM 
of complex unless stated otherwise. Reactions were initiated by addition of the Csm complex. The 
samples were collected at timed intervals and quenched by mixing 10 µl of reaction mixture with 2X 
RNA loading buffer (Thermo Scientific) followed by incubation for 10 min at 85°C. The reaction 
products were separated on a denaturing 20% PAAG and visualized by autoradiography. 32P-5¶-labeled 
RNA Decade marker (Ambion) was used as size marker. To map the cleavage products 
oligoribonucleotide markers were generated by RNase A (Thermo Scientific, final concentration 10 
ng/ml) treatment of RNA substrates for 8 min at 22qC or by alkaline hydrolysis in 50 mM NaHCO3 
(pH 9.5) at 95°C for 5 min. 
Phage drop plaque assay 
Phage drop plaque assay was conducted using LGC Standards recomendations (see Supplemental 
Experimental Procedures). 
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Figure 1. Cloning, isolation and characterization of the Type III-A Csm complex of S. 
thermophilus DGCC8004. (A) Schematic organization of the Type III-A CRISPR2 locus (see also 
Figure S1). Repeats and spacers are indicated by diamonds and rectangles, respectively, T is for the 
terminal repeat, L is for the leader sequence. Arrow indicate promoter. (B) PURWRVSDFHU36DQGWKH¶-
flanking sequence in the S. thermophilus phage O1205 genome. (C) Strategy for expression and 
isolation of the StCsm complex. Four copies of the spacer S3 have been engineered into the 
pCRISPR_S3 plasmid to increase the yield of the Csm-crRNA complex. (D) Coomassie blue-stained 
SDS-PAAG of Strep-tagged Csm2 and Csm3 pull-downs. 3N ± Csm3_StrepN protein, M ± protein 
mass marker. (E) Denaturing PAGE analysis of NA co-purifying with the Csm2_StrepN and 
Csm3_StrepN complexes. M ± synthetic DNA marker. (F) and (G) Characterization of crRNA in the 
isolated StCsm complexes. Cartoon models illustrate crRNA which co-purify with StCsm-72 and 
StCsm-40 complexes. Composition of the crRNA was determined using LC ESI MS analysis (see also 
Figure S2). IP RP HPLC analysis and ESI MS spectra of IP RP HPLC purified crRNA from StCsm-40 
and StCsm-72 are presented. (H) Superimposed averaged dummy atom models obtained from SAXS 
data of StCsm-40 (yellow beads) and StCsm-72 (blue beads) (see also Figure S3). 
Figure 2. Nucleic acid binding and cleavage by the Type III-A Csm complex of S. thermophilus. 
(A) Schematic representation of DNA and RNA substrates used for in vitro binding and cleavage 
DVVD\V1$ZHUHƍ- RU¶-end labeled with 32P (indicated as *). (B) EMSA analysis of DNA or RNA 
binding by StCsm-40. NS stands for a non-specific RNA. (C) Bing competition assay. 0.5 nM of 32P-
labelled S3/1 RNA was mixed with increasing amounts of unlabelled competitor NAs and 0.3 nM 
StCsm-40, and analysed by EMSA. (D) StCsm-40 cleavage assay. Gel-purified DNA or RNA were 
used as substrates in the NA cleavage assay. Triangles with corresponding numbers indicate cleavage 
product length. M ± RNA Decade marker, R ± RNase A digest marker, H ± alkaline hydrolysis marker. 
(E) RNA cleavage products mapped on the S3/1 RNA substrate sequence. Triangles and dashed lines 
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indicate cleavage positions. Short vertical lines above the sequence indicate nucleotides complementary 
to crRNA. crRNA (StCsm-40) sequence is depicted above the matching substrate fragments. 
Figure 3. The effect of the sequence complementarity outside the spacer region on the StCsm-72 
cleavage pattern. (A) Schematic representation of the StCsm-72 complex and RNA substrates used in 
WKHFOHDYDJHDVVD\51$VXEVWUDWHVZHUHƍ-end labeled with 32P (indicated as *) and gel-purified. (B) 
StCsm-72 cleavage assay. M ± RNA Decade marker. (C) RNA cleavage products mapped on the S3/2, 
S3/5 and S3/6 RNA substrates sequences. 
Figure 4. The effect of protospacer truncations on the StCsm-40 cleavage pattern. (A) Schematic 
representation of the StCsm-40 complex and RNA substrates used in the cleavage assay. RNA 
VXEVWUDWHVZHUHƍ-end labeled with 32P (indicated as *) and gel-purified. (B) StCsm-40 cleavage assay. 
M ± RNA Decade marker. (C) RNA cleavage products mapped on the RNA substrates sequences. 
Figure 5. Computational and mutational analysis of Csm3. (A) Alignment of Csm3 and Cmr4 
sequence representatives from experimentally characterized Type III effector complexes. Identical and 
similar residues in more than half of sequences are shaded in blue and green correspondingly. StCsm3 
positions subjected to site-directed mutations are indicated by triangles above the sequence. (B) 
Coomassie blue-stained SDS-PAAG of StCsm complexes containing Csm3 mutants. M ± protein 
marker. (C) Denaturing PAGE analysis of NA co-purifying with mutant StCsm complexes. M ± 
synthetic DNA marker. (D) EMSA analysis of S3/2 RNA binding by mutant StCsm complexes. (E) 
S3/2 RNA cleavage by the mutant StCsm complexes. (F) The cleavage rate constant kobs values for 
Csm3 mutant variants. 
Figure 6. Restriction of ssRNA phage MS2 in E. coli cells expressing StCsm complex. (A) Cartoon 
representation of assay. Arrow indicate promoter. (B) Phage plaque analysis. Serial 10-fold dilutions of 
MS2 were transferred onto lawns of E. coli NovaBlue (DE3, F+) strain expressing StCsm-crRNA 
complex targeting the MS2 genome or control cells. 
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Figure 7. Structural and cleavage models of StCsm complexes. Transcript of CRISPR region is first 
processed into 72 nt crRNA intermediate which undergoes further maturation into 40 nt crRNA. Both 
crRNAs are incorporated into StCsm complexes that target RNA but differ by the number of Csm3 and 
Csm2 subunits. The number of RNA cleavage products correlate with the number of Csm3 nuclease 
subunits. Schematic models of StCsm complexes were generated based on similarity to TtCmr and 
PfCmr. Csm analogs of Cmr proteins according to (Makarova et al., 2011a) are colored identically. 
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Figure S1 (related to Figure 1). 
 
 
Schematic organization of the Type III-A CRISPR-Cas systems of Streptococcus thermophilus 
DGCC8004, DGCC7710 (GenBank AWVZ01000003), LMD-9 (GenBank NC008532), 
Staphylococcus epidermidis RP62a (GenBank NC002976), Enterococcus italicus DSM15952 
(GenBank AEPV01000074), Lactococcus lactis DGCC7167 (GenBank JX524189) and 
Sulfolobus solfataricus P2 (GenBank AE006641)*. Arrows are colored according to the 
percentage of identical residues (Vector NTI AlignX tool) in Csm/Cas proteins in respect to the 
S. thermophilus DGCC8004. Conserved repeat sequences are shown in the inserts. Partially 
palindromic repeat sequences are indicated by arrows. In L. lactis DGCC7167 CRISPR2 system lch 
gene which shows a partial homology to the relE/parE toxin gene is present instead of cas2 (Millen 
et al., 2012). In CRISPR-Cas loci of S. thermophilus LMD-9 and S. solfataricus P2 cas10 is split in 
two open reading frames ORF1 and ORF2. 
 
* The Type III-A system of DGCC8004 contains 10 cas genes flanking the CRISPR2 array and 
includes cas1, cas2, cas6, cas10, csm2, csm3, csm4, csm5, csm6 and csm6’ genes. The DGCC8004 
CRISPR2 locus share similar gene arrangement to that of DGCC7710 (GenBank AWVZ00000000, 
(Horvath and Barrangou, 2010)) and LMD-9 (GenBank NC_008532, (Makarova et al., 2006)). The 
major difference is an additional csm6’ gene in DGCC8004. The Csm6’ protein in DGCC8004 is 
comprised of 386 aa and shows ~34% amino acid identity to the 428 aa Csm6 protein, suggesting a 
possible ancient gene duplication event followed by sequence divergence. In contrast, DGCC7710 
contains only a short 117-nt ORF in front of csm6. The Cas/Csm proteins associated to CRISPR2 in 
DGCC8004 are homologous to the corresponding proteins in DGCC7710 and LMD-9 (more than 
90% aa identity, except for the Csm2 protein, which shares ~70% identity). Other experimentally 
characterized Type III-A systems including S. epidermidis RP62a (GenBank NC002976, 
(Marraffini and Sontheimer, 2008)), Enterococcus italicus DSM15952 (GenBank AEPV01000074, 
(Millen et al., 2012)) and Lactococcus lactis DGCC7167 (GenBank JX524189, (Millen et al., 
2012)) share with DGCC8004 a conserved arrangement of the cas10-csm2-csm3-csm4-csm5-csm6 
gene cluster, while the position of cas6 and cas1/cas2 genes differ in some strains. The Type III-A 
signature protein Cas10 of DGCC8004 shows ~34-40% identity (~50-55% similarity) to Cas10 of 
S. epidermidis, E. italicus and L. lactis. In LMD-9, the cas10 gene is split into two ORFs which 
match to the N- and C-terminal fragments of Cas10 in DGCC8004 (> 92% identical aa). Type III-A 
CRISPR-Cas locus in S. solfataricus P2 (GenBank AE006641) has different gene organization and 
shows low protein sequence similarity to Cas/Csm orthologues in DGCC8004. Noteworthy, the 
Csm3 protein is most conserved among the Cas/Csm proteins across different strains and 5 copies 
of the Csm3 paralogues are present in S. solfataricus. Repeat sequences in S. epidermidis, 
Enterococcus italicus and Lactococcus lactis are of the same length (36 nt), however the nucleotide 
conservation is limited to the palindromic parts and 3’-terminal end of the repeats. The 8-nt 3’-
terminal sequence of the repeat, which may contribute to the crRNA 5’-handle, shows an 
ACGRRAAC consensus between S. thermophilus, S. epidermidis, E. italicus and L. lactis but 
differs from that of S. solfataricus (AUUGAAG (Rouillon et al., 2013)).  
Figure S2 (related to Figure 1). 
 
ESI MS/MS oligoribonucleotide mapping of crRNA isolated from StCsm-72 and StCsm-40. 
(A-C) ESI MS/MS oligoribonucleotide mapping of crRNA isolated from StCsm-72. (A) Base peak 
chromatogram of RNase T1 digest. RNase T1 cleaves single-stranded RNA 3’ of G residues. 
Predominant oligoribonucleotide peaks of the crRNA are highlighted. Masses of each 
oligoribonucleotide are presented in the table. The theoretical and experimental masses are shown 
for the oligoribonucleotides identified. (B) Base peak chromatogram of RNase A digest. RNase A 
cleaves single-stranded RNA 3’ of C or U residues. (C) ESI MS/MS analysis of the 
oligoribonucleotide GAGAGGGGp. Tandem MS was used to verify the oligoribonucleotide. The 
predominant fragment ions are highlighted.  
(D) ESI MS/MS oligoribonucleotide mapping of crRNA isolated from StCsm-40. Base peak 
chromatogram of RNase T1 digest. The oligoribonucleotide UUCACUUAUUC was unique to the 
40-nt crRNA. p = 3’-phosphate, >p = 2’3’-cyclic phosphate. 
Figure S3 (related to Figure 1). 
 
 
 
SAXS data for StCsm complexes. 
SAXS data for StCsm-40 (black dots) and StCsm-72 (red dots) are shown. (A) scattering profiles 
shown as a logarithmic plot of scattering intensity I(s) vs momentun transfer s = 4π sin(θ)/λ, where 
2θ is a scattering angle and λ is X-ray wavelength. (B) Kratky plot of SAXS data, I(s)*s2 vs s. (C) 
Guinier plots of SAXS data, ln I(s) vs s2 and its linear fit. The truncated first points are shown as 
open circles. (D) Distance distribution functions of StCsm-40 and StCsm-72 complexes calculated 
using GNOM (Svergun, 1992). (E) The electron density of the TtCmr (green beads), PfCmr (violet 
beads), and E. coli Cascade complexes (red beads) aligned with the StCsm-40 (yellow beads) 
model.
Figure S4 (related to Figure 2). 
 
Target RNA binding and cleavage by StCsm-72 and StCsm-40 complexes. 
(A) Schematic representation of S3/1 and S3/2 RNA substrates used in binding and cleavage assays. 
Nucleic acids were 5′-end labeled with 32P (indicated as *).  
(B) Electrophoretic mobility shift binding assay. The binding reactions contained 32P-labeled RNA 
(0.5 nM) and the Csm-72 or Csm-40 at concentrations indicated by each lane. Samples were 
analyzed by PAGE under non-denaturing conditions. NS shows the non-specific RNA control. 
(C) Cleavage assay. Cleavage reactions were performed at 37°C for Csm-72 and 25°C for Csm-40 
for indicated time intervals in the Reaction buffer supplemented with 10 mM Mg-acetate, 20 nM 
RNA substrate and 125 nM Csm-72 or 62.5 nM Csm-40. Samples were analyzed by denaturing 
PAGE, followed by phosphorimaging. In control experiments RNA substrate was incubated for 64 
min at 37°C or 36 min at 25°C in the Reaction buffer alone (“lane 0”) or the storage buffer was 
added instead of the Csm complex (“lane B”). Triangles denote the reaction products (the sizes of 
cleavage fragments are given near triangles). M – RNA Decade marker, R – oligoribonucleotide 
fragments generated from RNase A digestion of RNA, H – alkaline hydrolysis of RNA.  
(D) RNA cleavage products mapped on the RNA substrates sequence. Triangles and dashed lines 
indicate cleavage positions. Short vertical lines above the sequence indicate nucleotides 
complementary to crRNA. 40-nt and 72-nt crRNAs containing spacer S3 sequences are depicted 
above the matching substrate fragments. SP for specific RNA, NS for non-specific RNA. 
(E) Metal ion (Me2+) dependency of the RNA cleavage by the Csm complex. S3/1 RNA substrate 
was pre-incubated with Csm-40 and reaction products were analyzed in denaturating 
polyacrylamide gels. Cleavage reactions were conducted at 25°C for 3 min in Reaction buffer 
containing 20 nM 32P-5’-labelled gel purified S3/1 RNA substrate, 62.5 nM Csm-40 and 1 mM 
EDTA, 10 mM Mg-acetate, 10 mM MnCl2, 1 mM Ca-acetate, 0.1 mM ZnSO4, 0.1 mM NiCl2, 1 
mM or CuSO4. Triangles and numbers denote the reaction products and their sizes, respectively. M 
– RNA Decade marker.  
(F) S3/1 RNA cleavage pattern of the heterogeneous Csm-complex. To express and to purify 
heterogeneous Csm complex the wt CRISPR2 region containing 13 spacers of S. thermophilus 
DGCC8004 was cloned into the pACYC-Duet-1 vector. The heterogeneous Csm-72 complex was 
expressed and purified following the same procedure described for the homogenous Csm complex 
targeting the S3 protospacer. Specific S3/1 RNA substrate and non-specific NS RNA were pre-
incubated with heterogeneous Csm-72. Cleavage reactions were performed at 37°C for indicated 
time intervals in the Reaction buffer supplemented with 10 mM Mg-acetate, 20 nM RNA substrate 
and 350 nM heterogeneous Csm-72. Samples were analyzed by denaturing PAGE, followed by 
phosphorimaging. Triangles and numbers denote the reaction products and their sizes, respectively. 
M – RNA Decade marker.  
Figure S5 (related to Figure 2). 
 
Reprogramming of the StCsm complex to cut a desired RNA target. 
(A) Schematic representation (+Tc) and (-Tc) RNA substrates used in the cleavage assay. Arrow 
indicate TcR gene promoter. RNA substrates were 5′-end labeled with 32P (indicated as *) and gel 
purified. The Tc (tetracycline resistance protein) gene transcript or RNA corresponding to the non-
coding strand of Tc in the pBR322 plasmid (nt 851-886) were used as RNA targets. To reprogram a 
Csm complex a synthetic CRISPR locus containing five 36-nt length repeats interspaced by four 
identical 36-nt spacers complementary to the sense or antisense DNA strands of the Tc gene were 
engineered into the pACYC-Duet-1 plasmids which were independently co-expressed in E. coli 
together with plasmids pCsm/Cas and pCsmX-Tag. Csm-40 and Csm-72 complexes reprogrammed 
for the sence (+Tc) RNA or anti-sense (-Tc) RNA fragments were isolated similar to StCsm bearing 
spacer S3. 
(B) Cleavage reactions were performed at 37°C for 120 min in the Reaction buffer supplemented 
with 10 mM Mg-acetate, 20 nM gel purified RNA substrate and 40-120 nM of Csm complex. 
Samples were analyzed by denaturing PAGE, followed by phosphorimaging. Triangles with 
corresponding numbers indicate cleavage product length. M – RNA Decade marker.  
(C) RNA cleavage products mapped on the (+Tc) and (-Tc) RNA substrates sequences. The 
sequences of reprogrammed 40-nt and 72-nt length crRNAs are depicted above the substrates. Short 
vertical lines above the sequence indicate nucleotides complementary to crRNA. Triangles and 
dashed lines indicate cleavage positions. Translated fragment which corresponds to the tetracycline 
resistance protein gene RNA transcript is indicated under (+Tc) RNA substrate.  
Figure S6 (related to Figure 3). 
 
The role crRNA: target RNA complementarity on the StCsm-40 cleavage pattern. 
(A) Schematic representation of the StCsm-40 complex and RNA substrates used in the cleavage 
assay. RNA substrates were 5′ -end labeled with 32P (indicated as *) and gel purified. 
(B) Cleavage reactions were performed at 25°C for indicated time intervals in the Reaction buffer 
supplemented with 10 mM Mg-acetate, 20 nM RNA substrate and 62.5 nM Csm-40. Samples were 
analyzed by denaturing PAGE, followed by phosphorimaging. Triangles with corresponding 
numbers indicate cleavage product length. M – RNA Decade marker. 
(C) RNA cleavage products mapped on RNA substrates sequences. Short vertical lines above the 
sequence indicate nucleotides complementary to crRNA. Triangles and dashed lines indicate 
cleavage positions. The sequences of both 40-nt and 72-nt length crRNAs containing spacer S3 
present in Csm-40 preparation are depicted above the substrates.  
Figure S7 (related to Figure 5). 
 
 
Computational analysis of Csm3. 
(A-C) A structural model of StCsm3 in different representations. (A) Cartoon representation with 
the core RRM region shown in green and the „lid“ domain shown in yellow. Active site residue 
D33 is shown in red. (B) Molecular surface of the Csm3 model colored according to sequence 
conservation (maroon – conserved, cyan – variable). (C) Molecular surface of the Csm3 model 
colored according to electrostatic potential (blue – positive, red – negative). 
(D) Clustering of 604 Csm3 and Cmr4 sequence homologs with CLANS. Representatives of Csm3 
and Cmr4 families from experimentally characterized (Hale et al., 2009; Hatoum-Aslan et al., 2013; 
Hrle et al., 2013; Millen et al., 2012; Rouillon et al., 2013; Staals et al., 2013; Zhang et al., 2012) 
Type III CRISPR-Cas systems are labeled. Each dot represents a sequence, connecting lines 
represent the similarity between sequences. Thicker lines and shorted distances indicate higher 
sequence similarity. Only connections corresponding to P-values of 1e-12 or better are shown. 
Table S1 (related to Figure 1). Proteins identified following mass spectrometry analysis of StCsm-
72. 
 
Protein Mass (Da) Score 
Coverage 
(%) Peptides 
Cas10 86891 1076 36 LAYYLTR 
GDYAAIATR 
VYINQFASDK 
TVETLVQFEK 
YFKPTVLNLK 
YHMANYQSDK 
HNYKEDLFTK 
LYVAFGWGSFAAK 
DSISLFSSDYTFK 
DIMSELNSPESYR 
IDLFYGALLHDIGK 
DFNQFLLANFQTR 
FITNVYDDKLEQIR 
EKIDLFYGALLHDIGK 
GNEKDSISLFSSDYTFK 
IWDTYTNQADIFNVFGAQTDK 
SKPNFASATYEPFSKGDYAAIATR 
IWDTYTNQADIFNVFGAQTDKR 
HALVGADWFDEIADNQVISDQIR 
Csm3 24541 768 46 ITAEANPR 
FENTIDR 
TLNELLTAEV 
ATTVFGNYDVK 
LLELDYLGGSGSR 
LKATTVFGNYDVK 
VAEKPSDDSDILSR 
DPITNLPIIPGSSLK 
SYTEVKFENTIDR 
DAFLSNADELDSLGVR 
FENTIDRITAEANPR 
Csm4 33727 584 33 KQDLYK 
IFSALVLESLK 
DGNLYQVATTR 
HDQIDQSVDVK 
SSGFAFSHATNENYR 
FELDIQNIPLELSDR 
NQPHKDGNLYQVATTR 
LYIMTFQNAHFGSGTLDSSK 
Cas6 28240 197 16 LVFTFK 
LIFQSLMQK 
RIDHPAQDLAVK 
SQGSYVIFPSMR 
Csm2 14817 186 21 AQILEALK 
VQFVYQAGR 
YMEALVAYFK 
Csm5 41013 138 12 LISFLNDNR 
NHESFYEMGK 
DAFGNPYIPGSSLK 
 
Table S2 (related to Figure 1). Proteins identified following mass spectrometry analysis of StCsm-
40. 
 
Protein Mass (Da) Score Coverage (%) Peptides 
Cas10 86891 1149 30 LAYYLTR 
GDYAAIATR 
VYINQFASDK 
YFKPTVLNLK 
YFFNHQDER 
YHMANYQSDK 
HNYKEDLFTK 
LYVAFGWGSFAAK 
DSISLFSSDYTFK 
DIMSELNSPESYR 
IDLFYGALLHDIGK 
DFNQFLLANFQTR 
FITNVYDDKLEQIR 
EKIDLFYGALLHDIGK 
GNEKDSISLFSSDYTFK 
IWDTYTNQADIFNVFGAQTDK 
SKPNFASATYEPFSKGDYAAIATR 
IWDTYTNQADIFNVFGAQTDKR 
HALVGADWFDEIADNQVISDQIR 
Csm3 24541 801 57 ITAEANPR 
FENTIDR 
TLNELLTAEV 
ATTVFGNYDVK 
LLELDYLGGSGSR 
LKATTVFGNYDVK 
VAEKPSDDSDILSR 
DPITNLPIIPGSSLK 
SYTEVKFENTIDR 
DAFLSNADELDSLGVR 
FENTIDRITAEANPR 
NSTFDFELIYEITDENENQVEEDFK 
Csm4 33727 554 33 KQDLYK 
IFSALVLESLK 
DGNLYQVATTR 
HDQIDQSVDVK 
SSGFAFSHATNENYR 
FELDIQNIPLELSDR 
FELDIQNIPLELSDRLTK 
NQPHKDGNLYQVATTR 
SSGFGEFELDIQNIPLELSDR 
Cas6 28240 171 16 LVFTFK 
LIFQSLMQK 
RIDHPAQDLAVK 
SQGSYVIFPSMR 
Csm2 14817 110  AQILEALK 
VQFVYQAGR 
Csm5 41013 965 50 WDYSAK 
QADGILQR 
EFIYENK 
FYFPDMGK 
TILMNTTPK 
KFYFPDMGK 
VSDSKPFDNK 
LISFLNDNR 
NHESFYEMGK 
EYDDLFNAIR 
WNNENAVNDFGR 
GKEYDDLFNAIR 
KGKEYDDLFNAIR 
IEFEITTTTDEAGR 
LSLLTLAPIHIGNGEK 
DAFGNPYIPGSSLK 
LAEKFEAFLIQTRPNAR 
Table S3 (related to Figures 1). MW estimations for StCsm-40 and StCsm-72 by different methods. 
 
 
SDS-PAGE, 
kDa * DLS, kDa 
**
 
MoW server, 
kDa *** 
Porod volume, 
kDa *** 
DAMMIN 
models, kDa **** 
Csm-40 344.8 305±75 302±9 282±15 347.5 
Csm-72 486.2 523±128 425±15 350±9 465.6 
 
*
 Molecular mass calculated from evaluation of the complex composition by densitometric analysis 
of the SDS-PAGE gels. 
**
 Molecular mass calculated from dynamic light scattering (DLS) analysis. 
***
 Molecular mass calculated from the SAXS data by the method described in (Fischer et al., 2010) 
using the SAXS MoW program run on the server http://www.if.sc.usp.br/~saxs/saxsmow.html. 
****
 Molecular mass was estimated using the Porod volumes calculated from SAXS data and 
excluded volumes of DAMMIN models as described in (Petoukhov et al., 2012). 
 
Table S4 (related to Figure 1). SAXS data collection details and structural parameters of StCsm-40 
and StCsm-72 complexes*. 
 
Data collection parameters 
Beam line P12 
Wavelength, nm 0.124 
Sample to detector distance, m 3.1 
Detector Pilatus 2M 
s range, nm-1 0.075786 - 4.665330 
exposure time of each frame, s 0.05 
Frames collected 20 
Sample storage temperature, °C 10 
Cell temperature, °C 20 
Structural parameters 
 Csm-40 Csm-72 
Sample concentrations, mg/ml 0.13 0.52 1.34 0.20 0.65 2.00 
Guinier range (first-last point) as 
calculated by AUTORG 14-53 26-55 19-52 8-35 21-39 11-34 
P(r) calculation range, Å-1 0.0114-0.2006 
0.0114-
0.2006 
0.0117-
0.1739 
0.0089-
0.1076 
0.0108-
0.1076 
0.0084-
0.1049 
Real space Rg, calculated by 
GNOM, Å 
63.59 
±0.414 
62.80 
±0.329 
63.20 
±0.163 
83.82 
±0.545 
81.40 
±0.333 
83.14 
±0.287 
Real space Rg calculated by 
DATGNOM, Å 64.02 62.35 63.26 84.15 81.69 84.51 
Reciprocal space Rg calculated by 
DATGNOM, Å 68.08 58.04 61.34 81.51 79.71 83.79 
Dmax as parameter for GNOM, Å 210 208 215 275 265 280 
Dmax calculated by DATGNOM, Å 233.2 203.1 214.7 279.2 267.0 293.3 
Porod volume estimated by 
DATPOROD, Å3 452186 501468 485803 611618 589997 581121 
Excluded volume of DAMMIN 
models, Å3 (10 models averaged)   
590770± 
5209   
791440± 
11366 
 
 
Table S5 (related to Figures 2, 3, 4, 5, and 6). Nucleic acid substrates used in this study*. 
 
S3 crRNA in Csm-72             5'-handle              Spacer S3                           3'-handle 
            5’-ACGGAAACUUUCGUAACUGUUUAAUUCUGUUCACUUAUUCCACCGAUAUAAACCUAAUUACCUCGAGAGGGG-3’ 
S3 crRNA in Csm-40             5'-handle              Spacer S3 
            5’-ACGGAAACUUUCGUAACUGUUUAAUUCUGUUCACUUAUUC-3’ 
 
Substrates Length, nt Sequence 
S3/1 DNA/DNA  76/76 
5’-GGAGCTCGCCACCTTTTGTTTTTCGTAACTGTTTAATTCTGTTCACTTATTCCACCTCCTCAATTTGCCGGCTTGG-3’ 
3’-CCTCGAGCGGTGGAAAACAAAAAGCATTGACAAATTAAGACAAGTGAATAAGGTGGAGGAGTTAAACGGCCGAACC-5’ 
               O1205                                         O1205 
NS DNA/DNA  73/73 5’-GACCACCCTTTTTGATATAATATACCTATATCAATGGCCTCCCACGCATAAGCGCAGATACGTTCTGAGGGAA-3’ 3’-CTGGTGGGAAAAACTATATTATATGGATATAGTTACCGGAGGGTGCGTATTCGCGTCTATGCAAGACTCCCTT-5’ 
S3/2 DNA/DNA  52/52             5’-TTTTTTTTTTTCGTAACTGTTTAATTCTGTTCACTTATTCCACCTTATATTT-3’ 
            3’-AAAAAAAAAAAGCATTGACAAATTAAGACAAGTGAATAAGGTGGAATATAAA-5’ 
S3/1 DNA/RNA  76/68 
5’-GGAGCTCGCCACCTTTTGTTTTTCGTAACTGTTTAATTCTGTTCACTTATTCCACCTCCTCAATTTGCCGGCTTGG-3’ 
     3’-AGCGGUGGAAAACAAAAAGCAUUGACAAAUUAAGACAAGUGAAUAAGGUGGAGGAGUUAAACGGCGGG-5’ 
               O1205                                         O1205 
S3/2 DNA/RNA  52/68             5’-TTTTTTTTTTTCGTAACTGTTTAATTCTGTTCACTTATTCCACCTTATATTT-3’ 
     3’-CCAUGGGAAAAAAAAAAAGCAUUGACAAAUUAAGACAAGUGAAUAAGGUGGAAUAUAAACCCCUAGGG-5’ 
S3/1 DNA  76 
                       ||||||||||||||||||||||||||||||||||||  | |||              
3’-CCTCGAGCGGTGGAAAACAAAAAGCATTGACAAATTAAGACAAGTGAATAAGGTGGAGGAGTTAAACGGCCGAACC-5’ 
               O1205                                         O1205 
NS DNA  73 3’-CTGGTGGGAAAAACTATATTATATGGATATAGTTACCGGAGGGTGCGTATTCGCGTCTATGCAAGACTCCCTT-5’ 
S3/2 DNA  52                        ||||||||||||||||||||||||||||||||||||         
            3’-AAAAAAAAAAAGCATTGACAAATTAAGACAAGTGAATAAGGTGGAATATAAA-5’ 
S3/1 RNA  68 
                       ||||||||||||||||||||||||||||||||||||  | |||       | | 
     3’-AGCGGUGGAAAACAAAAAGCAUUGACAAAUUAAGACAAGUGAAUAAGGUGGAGGAGUUAAACGGCGGG-5’ 
               O1205                                         O1205 
NS RNA 68 
                         | | |   ||  |      |  ||   | | |    | |||       | | 
     3’-AGCGGUGGAAAACAACCACCUUAUUCACUUGUCUUAAUUUGUCAAUGCUUUAGGAGUUAAACGGCGGG-5’ 
               O1205                                         O1205 
S3/2 RNA  68                        ||||||||||||||||||||||||||||||||||||            ||| | 
     3’-CCAUGGGAAAAAAAAAAAGCAUUGACAAAUUAAGACAAGUGAAUAAGGUGGAAUAUAAACCCCUAGGG-5’ 
S3/3 RNA  68                ||||||||||||||||||||||||||||||||||||||||||||            ||| | 
     3’-CCAUGGGUGCCUUUGAAAGCAUUGACAAAUUAAGACAAGUGAAUAAGGUGGAAUAUAAACCCCUAGGG-5’ 
S3/4 RNA  68                         ||||||||||||||||||||||||||||||||||||||||||||||||||| | 
     3’-CCAUGGGAAAAAAAAAAAGCAUUGACAAAUUAAGACAAGUGAAUAAGGUGGCUAUAUUUGGAUUAGGG-5’ 
S3/5 RNA  68 
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| | 
     3’-CCAUGGGUGCCUUUGAAAGCAUUGACAAAUUAAGACAAGUGAAUAAGGUGGCUAUAUUUGGAUUAGGG-5’ 
 
Substrates Length, nt Sequence 
S3/6 RNA 86                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
     3’-CCAUGGGUGCCUUUGAAAGCAUUGACAAAUUAAGACAAGUGAAUAAGGUGGCUAUAUUUGGAUUAAUGGAGCUCUCCCCUGCCGGG-5’ 
S3/7 RNA  68                        ||  ||||||||||||||||||||||||||||||||            ||| | 
     3’-CCAUGGGAAAAAAAAAAUCCAUUGACAAAUUAAGACAAGUGAAUAAGGUGGAAUAUAAACCCCUAGGG-5’ 
S3/8 RNA  68                        ||||||||||||||||||||||||||||||||  ||            ||| | 
     3’-CCAUGGGAAAAAAAAAAAGCAUUGACAAAUUAAGACAAGUGAAUAAGCAGGAAUAUAAACCCCUAGGG-5’ 
S3/9 RNA  68                        |||||||||||||||||  |||||||||||||||||            ||| | 
     3’-CCAUGGGAAAAAAAAAAAGCAUUGACAAAUUAUCACAAGUGAAUAAGGUGGAAUAUAAACCCCUAGGG-5’ 
S3/11 RNA 24                                |||||||||||||||||||||||| 
                            3’-GACAAAUUAAGACAAGUGAAUGGG-5’ 
S3/12 RNA 32                        |||||||||||||||||||||||||||||||| 
                    3’-AAAGCAUUGACAAAUUAAGACAAGUGAAUGGG-5’ 
S3/13 RNA 23                        |||||||||||||||||||| || 
                    3’-AAAGCAUUGACAAAUUAAGAGGG-5’ 
S3/14 RNA  48                        ||||||||||||||||||||||||||||||||| 
     3’-CCAUGGGAAAAAAAAAAAGCAUUGACAAAUUAAGACAAGUGAAUAAGG-5’ 
 
 
 
 
crRNA (+Tc) in Csm-72             5'-handle            Spacer(+Tc)                           3'-handle 
            5’-ACGGAAACACGCCAGCAAGACGUAGCCCAGCGCGUCGGCCGCCAGAUAUAAACCUAAUUACCUCGAGAGGGG-3’ 
crRNA (+Tc) in Csm-40             5'-handle            Spacer(+Tc) 
            5’-ACGGAAACACGCCAGCAAGACGUAGCCCAGCGCGUCGGCC-3’ 
Substrate Length, nt Sequence 
RNA (+Tc) 68                        ||||||||||||||||||||||||||||||||||||  |        |  | | 
     3’-UCGGAGCGCAGCGCUUGCGGUCGUUCUGCAUCGGGUCGCGCAGCCGGCGGUACGGCCGCUAUUACGGG-5’ 
 
crRNA (-Tc) in Csm-72             5'-handle            Spacer(-Tc)                         3'-handle 
            5’-ACGGAAACUGGCGGCCGACGCGCUGGGCUACGUCUUGCUGGCGUGAUAUAAACCUAAUUACCUCGAGAGGGG-3’ 
crRNA (-Tc) in Csm-40             5'-handle            Spacer(-Tc) 
            5’-ACGGAAACUGGCGGCCGACGCGCUGGGCUACGUCUUGCUG-3’ 
Substrate Length, nt Sequence 
RNA (-Tc) 68                        ||||||||||||||||||||||||||||||||||||     |  |    || | 
     3’-GGUAAUAGCGGCCGUACCGCCGGCUGCGCGACCCGAUGCAGAACGACCGCAAGCGCUGCGCUCCGGGG-5’ 
 
 
 
 
 
Rep crRNA in Csm-72             5'-handle            Spacer Rep                           3'-handle 
            5'-ACGGAAACCAACGAGCCUAAAUUCAUAUGACUCGUUAUAGCGGAGAUAUAAACCUAAUUACCUCGAGAGGGG-3' 
Rep crRNA in Csm-40             5'-handle            Spacer Rep 
            5'-ACGGAAACCAACGAGCCUAAAUUCAUAUGACUCGUUAUAG-3' 
Substrate Length, nt Sequence 
Rep RNA  72                        ||||||||||||||||||||||||||||||||||||        |  | ||||  || | |  | 
            3'-CAAGGGAUGUUGCUCGGAUUUAAGUAUACUGAGCAAUAUCGCCUGGCGCACAGACUAGGUGCCGCGUGUAAC-5' 
 
 
Lys crRNA in Csm-72             5'-handle            Spacer Lys                           3'-handle 
            5'-ACGGAAACUGUCUUCGACAUGGGUAAUCCUCAUGUUUGAAUGGCGAUAUAAACCUAAUUACCUCGAGAGGGG-3' 
Lys crRNA in Csm-40             5'-handle            Spacer Lys 
            5'-ACGGAAACUGUCUUCGACAUGGGUAAUCCUCAUGUUUGAA-3' 
Substrate Length, nt Sequence 
Lys RNA 72                        ||||||||||||||||||||||||||||||||||||          || |     |  ||| 
            3'-AAGAAACAACAGAAGCUGUACCCAUUAGGAGUACAAACUUACCGGCCGCAGAUAAUCAUCUACGGCCUCAAA-5' 
 
 
Cp crRNA in Csm-72             5'-handle            Spacer Cp                           3'-handle 
            5'-ACGGAAACUCUUUUAGGAGACCUUGCAUUGCCUUAACAAUAAGCGAUAUAAACCUAAUUACCUCGAGAGGGG-3' 
Cp crRNA in Csm-40             5'-handle            Spacer Cp 
            5'-ACGGAAACUCUUUUAGGAGACCUUGCAUUGCCUUAACAAU-3' 
Substrate Length, nt Sequence 
Cp RNA  72                        ||||||||||||||||||||||||||||||||||||           | ||    ||||||  | 
            3'-CCAAAGGUAGAAAAUCCUCUGGAACGUAACGGAAUUGUUAUUCGAGCGUCAGCCUUAAGCAUCGCUUUUAAC-5' 
 
 
Mat crRNA in Csm-72             5'-handle            Spacer Mat                           3'-handle 
            5'-ACGGAAACAGUUUGCAGCUGGAUACGACAGACGGCCAUCUAACUGAUAUAAACCUAAUUACCUCGAGAGGGG-3' 
Mat crRNA in Csm-40             5'-handle            Spacer Mat 
            5'-ACGGAAACAGUUUGCAGCUGGAUACGACAGACGGCCAU-3' 
Substrate Length, nt Sequence 
Mat RNA  72                        ||||||||||||||||||||||||||||||||||||       |        |      | || 
            3'-ACAGACCUUCAAACGUCGACCUAUGCUGUCUGCCGGUAGAUUGAACUACAAUCAUGGCUGGACUGCAUGCCG-5' 
 
* Above each Table crRNAs in Csm-72 and Csm-40 are depicted for clarity. Bold lettering in crRNAs represents the spacer (guide) sequence. Non-bold regions in crRNAs is for repeat 
sequences. Designed 72 and 40 nt crRNAs (+Tc) are complementary to tetracycline resistance gene (Tc) transcript and are guided to cleave RNA(+Tc) substrate (sence RNA or Tc transcript). 
Similarly, designed 72 and 40 nt crRNAs (-Tc) are guided to cleave RNA (-Tc) (antisence RNA corresponding the non-coding strand of Tc gene) substrate. Designed Rep, Lys, Cp and Mat 72 
and 40 nt crRNAs are guided to cleave ss RNA coliphage MS2 rep, lys, cp and mat transcripts, respectively. 
DNA and RNA substrates used in this study are presented in the Tables. Bold lettering in substrates represents the sequence complementary to spacer (guide) of crRNA. For single stranded 
DNA and RNA substrates nucleotides complementary to corresponding nucleotide in crRNA are depicted by dashes. Nucleotides marked in yellow were incorporated into RNA during in vitro 
transcription. Rep, Lys, Cp and Mat RNA are RNA sequences in MS2 genome. 
 
Supplemental Experimental Procedures  
 
Cloning, expression and purification of StCsm complexes  
Streptococcus thermophilus DGCC8004 was cultivated at 42°C in M17 broth (Oxoid) 
supplemented with 0.5% (w/v) lactose. Chromosomal DNA was extracted and purified using 
GeneJET Genomic DNA Purification Kit (Thermo Scientific). CRISPR2-Cas region was amplified 
by polymerase chain reaction (PCR) and sequenced using primers designed by genomic comparison 
with S. thermophilus DGCC7710 (GenBank accession number AWVZ01000003). Annotation of 
the predicted ORFs was performed using BLASTP at NCBI 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi). CRISPR region was identified through repeat sequence 
similarity to that of S. thermophilus DGCC7710. Multiple sequence alignments of cas/csm genes, 
spacers and repeats sequences were carried out with ClustalW2 (http://www.ebi.ac.uk). 
Genomic DNA isolated from S. thermophilus DGCC8004 strain was used as the template for PCR 
amplification of the cas/csm genes. DNA fragment covering the 8.5 kb cas6-cas10-csm2-csm3-
csm4-csm5-csm6-csm6’ gene cassette was cloned into pCDFDuet-1 expression vector via NcoI and 
AvrII restriction sites in two separate subcloning steps to generate plasmid pCas/Csm. Individual 
cas/csm genes were cloned into pETDuet-1_N-StrepII and pETDuet-1_C-StrepII expression 
vectors, except of cas10 (which was cloned into pBAD24_C-His-StrepII-His) and csm6 or csm6’ 
(that were cloned into pBAD24_N-His-StrepII-His) to generate pCsmX-Tag and pCasY-Tag 
plasmids, where X=2,3,4,5,6,6’ and Y=6,10. A synthetic 445-nt CRISPR locus containing five 36-
nt length repeats interspaced by four identical 36-nt spacers S3 of the S. thermophilus DGCC8004 
CRISPR2 system was obtained from Invitrogen and cloned into the pACYC-Duet-1 vector to 
generate a plasmid pCRISPR_S3. Four copies of the spacer S3 have been engineered into the 
pCRISPR_S3 plasmid to increase the yield of the Csm-crRNA complex. Full sequencing of cloned 
DNA fragments confirmed their identity to the original sequences. 
All three plasmids were co-expressed in Escherichia coli BL21 (DE3) grown at 37°C in LB 
medium supplemented with streptomycin (25 µg/µl), ampicilin (50 µg/µl), and chloramphenicol (30 
µg/µl). The fresh LB medium was inoculated with an overnight culture (1/20 (v/v)), and bacteria 
were grown to the mid-log phase (OD600nm 0.5 to 0.7), then 1 mM IPTG (and 0.2% (w/v) L-(+)-
arabinose in case of Cas10, Csm6 and Csm6’) was added and cell suspension was further cultured 
for another 4 h. Harvested cells were resuspended in a Chromatography buffer (20 mM Tris-HCl 
(pH 8.5), 0.5 M NaCl, 7 mM 2-mercaptoethanol, 1 mM EDTA) supplemented with 0.1 mM 
phenylmethylsulfonyl fluoride (PMSF), and disrupted by sonication. Cell debris was removed by 
centrifugation. Csm complexes were captured on the StrepTrap affinity column (GE Healthcare) 
and further subjected to the Superdex 200 size exclusion chromatography (prep grade XK 16/60; 
GE Healthcare). SDS-PAGE of individual Strep-tagged Csm2, Csm3, Csm4, Csm5, Cas6 and 
Cas10 proteins isolated by affinity chromatography from E. coli lysates revealed co-purification of 
other Csm/Cas proteins suggesting the presence of a Csm complex. The abundance of the Csm 
complex co-purified via the Csm4-, Csm5-, Cas6- and Cas10-Strep tagged subunits was very low, 
and no complex was pull-downed via Csm6 or Csm6’ subunits (data not shown). Therefore, Csm 
complexes isolated via N-terminus Strep-tagged Csm2 (Csm2_StrepN) and the N-terminus Strep-
tagged Csm3 proteins (Csm3_StrepN) were subjected to further characterization. Individual Csm3-
N-Strep protein was purified using StrepTrap affinity column. Csm3-N-Strep and Csm complexes 
eluted from the columns were dialysed against 10 mM Tris-HCl (pH 8.5) buffer containing 300 mM 
NaCl, 1 mM DTT, 0.1 mM EDTA, and 50% (v/v) glycerol, and stored at -20°C.  
The composition of the isolated Csm-40 and Csm-72 complexes was analysed by SDS–PAGE and 
the sequence of Csm proteins was further confirmed by the mass spectrometry of tryptic digests. In 
order to estimate the stoichiometry of Csm complexes, protein bands in SDS-PAGE were quantified 
by densitometric analysis taking a count the different staining of Cas/Csm proteins. The molecular 
weights of the Csm complexes were estimated by dynamic light scattering (DLS) using Zetasizer 
µV (Malvern) and respective software. For DLS analysis Csm-40 and Csm-72 samples were 
analysed in a Chromatography buffer at 0.36 mg/ml and 0.6 mg/ml concentrations, respectively. 
Csm complex concentrations were estimated by Pierce 660nm Protein Assay (Thermo Scientific) 
using bovine serum albumin (BSA) as a reference protein. Conversion to molar concentration was 
performed assuming that the Csm-72 stoichiometry is Cas101:Csm26:Csm310:Csm41:crRNA721 and 
the Csm-40 stoichiometry is Cas101:Csm23:Csm35:Csm41:Csm51:crRNA401. 
 
HPLC purification of crRNA 
All samples were analyzed by ion-pair reversed-phased-HPLC (Dickman and Hornby, 2006; 
Waghmare et al., 2009) on an Agilent 1100 HPLC with UV260nm detector (Agilent) using a 
DNAsep column 50 mm x 4.6 mm I. D. (Transgenomic). The chromatographic analysis was 
performed using the following buffer conditions: A) 0.1 M triethylammonium acetate (TEAA) (pH 
7.0) (Fluka); B) buffer A with 25% LC MS grade acetonitrile (v/v) (Fisher). The crRNA was 
obtained by injecting purified intact Csm-40 or Csm-72 at 75°C using a linear gradient starting at 
15% buffer B and extending to 60% B in 12.5 min, followed by a linear extension to 100% B over 2 
min at a flow rate of 1.0 ml/min. Analysis of the 3’ terminus was performed by incubating the 
HPLC-purified crRNA in a final concentration of 0.1 M HCl at 4°C for 1 hour. The samples were 
concentrated to 10-20 l on a vacuum concentrator (Eppendorf) prior to ESI-MS analysis. 
 
ESI-MS analysis of crRNA 
Electrospray Ionization Mass spectrometry (ESI-MS) was performed in negative mode using an 
Amazon Ion Trap mass spectrometer (Bruker Daltonics), coupled to an online capillary liquid 
chromatography system (Ultimate 3000, Dionex, UK). RNA separations were performed using a 
monolithic (PS-DVB) capillary column (50 mm × 0.2 mm I.D., Dionex, UK). The chromatography 
was performed using the following buffer conditions: C) 0.4 M 1,1,1,3,3,3,-Hexafluoro-2-propanol 
(HFIP, Sigma- Aldrich) adjusted with triethylamine (TEA) to pH 7.0 and 0.1 mM TEAA, and D) 
buffer C with 50% methanol (v/v) (Fisher). RNA analysis was performed at 50°C with 20% buffer 
D, extending to 40% D in 5 min followed by a linear extension to 60% D over 8 min at a flow rate 
of 2 l/min, 250 ng crRNA was digested with 1U RNase A/T1 (Applied Biosystems). The reaction 
was incubated at 37oC for 4 h. The oligoribonucleotide mixture was separated on a PepMap C-18 
RP capillary column (150 mm × 0.3 µm I.D., Dionex, UK) at 50°C using gradient conditions 
starting at 20% buffer C and extending to 35% D in 3 mins, followed by a linear extension to 60% 
D over 40 mins at a flow rate of 2 l /min. The mass spectrometer was operated in negative mode, a 
capillary voltage was set at -2500 V to maintain capillary current between 30−50 nA , temperature 
of nitrogen 120°C at a flow rate of 4.0 L/h and N2 nebuliser gas pressure at 0.4 bar. A mass range of 
500-2500 m/z was set. Oligoribonucleotides with -2 to -4 charge states were selected for tandem 
mass spectrometry using collision induced dissociation. 
 
SAXS experiments 
Ab initio shape modeling of both complexes was performed with the samples having highest 
concentration (1.3 mg/ml for Csm-40 and 2.0 mg/ml for Csm-72). Unprocessed scattering data with 
subtracted buffer scattering, Guinier plots of the low s region of the scattering curves used for the 
shape determination and P(r) functions of the highest concentration samples of Csm-40 and Csm-72 
are presented in Figure S3. Two-dimensional scattering curves were transformed and distance 
distribution functions P(r) were calculated using GNOM (Svergun, 1992). At this stage data were 
truncated to s values 0.15-0.1 Å-1 and calculated distance distribution function was used for 
following ab initio modeling. 10 independent bead models for both complexes were generated using 
DAMMIN (Svergun, 1999). These models were aligned, filtered and averaged based on occupancy 
using DAMAVER (Volkov and Svergun, 2003). The averaged NSD of superposition of DAMMIN 
models of Csm-40 complex was 0.563±0.028 (for Csm-72 models averaged NSD is 0.575±0.019), 
no model was rejected in both cases. 
The inertia tensor was calculated for averaged models of both complexes and models were aligned 
along the largest principal axis so as the end points of both models coincided. After that the 
protruding part of the longer Csm-72 complex was truncated. Csm-40 model was aligned with 
truncated Csm-72 models by automatic procedure SUPCOMB (Kozin and Svergun, 2001) 
producing an NSD value. Then Csm-40 model was shifted along the principal axis of Csm-72 
model by the fixed step (5 or 10 Å) and again Csm-40 model was aligned by SUPCOMB with the 
Csm-72 model after truncation of protruding parts. Thus the Csm-40 model was sequentially shifted 
along the principal axis of Csm-72 model and the best superposition showed the lower NSD value 
(S. Grazulis, personal communication). MOLSCRIPT (Kraulis, 1991) and RASTER3D (Merritt and 
Bacon, 1997) programs were used for SAXS models presented in Figure 1 and S3 preparation. 
 
Computational sequence and structure analysis 
Sequence searches were performed with PSI-BLAST (Altschul et al., 1997) against the nr80 
sequence database (the NCBI ‘nr’ database filtered to 80% identity) using E-value=1e-03 or a more 
stringent inclusion threshold. Clustering of homologous sequences according to their mutual 
similarity was done using CLANS (Frickey and Lupas, 2004). Multiple sequence alignments were 
constructed with MAFFT (Katoh et al., 2002) using the accuracy-oriented mode (L-INS-i). 
Homology model for StCsm3 was constructed with HHpred (Söding et al., 2005) using the related 
structure of M. kandleri Csm3 (PDB code 4N0L) as a template. The analysis of surface residue 
conservation was performed using the ConSurf server (Ashkenazy et al., 2010). Electrostatic map of 
the structure surface was calculated with the APBS (Baker et al., 2001) plugin in PyMol 
(Schrodinger, 2010). Pictures were prepared with PyMol (Schrodinger, 2010). 
 
Mutagenesis of Csm3 
The Csm3 mutants H19A, D33A, D100A, E119A, E123A and E139A were obtained by the Quick 
Change Mutagenesis (QCM) Protocol (Zheng et al., 2004). First, a 3.0 kb DNA fragment containing 
csm2 and csm3 genes was subcloned from pCas/Csm plasmid into the pUC18 vector pre-cleaved 
with SphI and KpnI. The resulting plasmid pUC18_Csm2_Csm3 was used for Csm3 QCM 
mutagenesis. After QCM, the same fragment containing mutated versions of the Csm3 gene was 
transferred back into the pCas/Csm vector using NdeI and SpeI sites, reconstituting the gene 
cassette. Sequencing of the entire cloned DNA fragment for each mutant confirmed that only the 
designed mutation had been introduced. Csm-40 complexes containing Csm3 mutants were isolated 
following the procedures described for the wt StCsm-40 (see above). D100A mutant StCsm-40 was 
purified only by the affinity chromatography. 
 
Preparation of DNA and RNA substrates 
To assemble DNA oligoduplexes, complementary oligodeoxynucleotides were mixed at 1:1 molar 
ratio in the Reaction buffer (33 mM Tris–acetate (pH 7.9 at 25C), 66 mM potassium acetate), 
heated to 90C and slowly let to cool to room temperature.  
For generation of S3/1-10, S3/14 RNA substrates, first pUC18 plasmids pUC18_S3/1 and 
pUC18_S3/2, bearing S3/1 or S3/2 sequences were constructed. For this purpose, annealed 
synthetic DNA oligoduplexes S3/1 or S3/2 were ligated into pUC18 plasmid pre-cleaved with 
SmaI. Engineered plasmids pUC18_S3/1 and pUC18_S3/2 were sequenced to persuade that only 
copy of DNA duplex was ligated into the vector. Further these plasmids were used as a template to 
produce different DNA fragments by PCR using appropriate primers containing a T7 promoter in 
front of the desired RNA sequence. Purified PCR products were used in the in vitro transcription 
reaction to obtain RNA substrates. S3/11-13 RNAs were prepared by hybridizing two 
complementary DNA oligonucleotides, containing a T7 promoter in front of the desired RNA 
sequence followed by in vitro transcription.  
DNA/RNA hybrids were assembled in similar manner annealing complementary 
oligodeoxynucleotide to RNA obtained by in vitro transcription.  
pBR322 plasmid bearing the Tc gene, encoding tetracycline (Tc) resistance protein, was used to 
produce Tc RNA and ncTc RNA substrates using the same in vitro transcription reaction as 
described above for S3/1-10, S3/14. Prior to 32P labeling RNA substrates were dephosphorylated 
using FastAP thermosensitive alkaline phosphatase (Thermo Scientific). 
 
Phage drop plaque assay 
Phage drop plaque assay was conducted using LGC Standards recomendations. Briefly, E. coli 
NovaBlue (DE3) [(endA1 hsdR17(r K12– m K12+) supE44 thi-1 recA1 gyrA96 relA1 lac (DE3) 
F'[proA+B+ lacI q ZM15::Tn10] (TetR)] was trasformed with wt pCas/Csm (StrR) or D33A Csm3 
pCas/Csm (StrR) and pCRISPR_MS2 (CmR), pCRISPR_S3 (CmR), or pACYC-Duet-1 (CmR). 
E. coli cells bearing different sets of plasmids were grown in LB medium with appropriate 
antibiotics at 37C to an OD 600 of 0.9 and a 0.4 ml aliquot of bacterial culture was mix ed with 
melted 0.5% soft nutrient agar (45°C). This mixture was poured onto 1.5% solid agar to make 
double layer agar plates. Both layers of agar contained appropriate antibiotics, 0,1mM IPTG, 0,1 
glucose, 2mM CaCl2 and 0,01mg/ml thiamine. When the top agar hardened, phage stock (5 l) from 
a dilution series was spotted on each plate with the bacteria. The plates were examined for cell lysis 
after overnight incubations at 37°C. NovaBlue (DE3) was used as the indicator for determination of 
the phage titer. pCRISPR_MS2 plasmid bearing the synthetic CRISPR array of five repeats 
interspaced by four 36-nt spacers targeting the mat, lys, cp, and rep MS2 RNA sequences (GenBank 
accession number NC001417) was constructed similar to pCRISPR_S3 (see above). 
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